Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Gefitinib can cause hair loss without scarring.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Baricitinib may effectively treat oral lichen planus.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Axitinib treatment turned a man's grey hair back to black.

Baricitinib is the most effective treatment for alopecia areata.

Biosimilars lower costs but don't significantly improve access.

Some blood thinners can cause hair loss, but switching medications can stop it.

Baricitinib can cause excessive hair growth.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Baricitinib may not always prevent relapse in alopecia areata.

JAK inhibitors are effective for long-term management of alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.